Semaglutide medication may benefit 93 million US adults
Researchers from the University of California, Irvine, have published a study that projects 93 million US adults that are overweight and...
top of page
Browse by category
Search
Analysis of STEP clinical trials shows semaglutide more than halves risk of T2DM
The risk of type 2 diabetes mellitus (T2DM) is more than halved by weekly injections of new obesity drug semaglutide, according to...
STEP outcomes: Semaglutide could be ‘gamechanger’ in battle against obesity
One third (35%) of patients who received semaglutide for treating obesity lost more than one-fifth (greater than or equal to 20%) of...
Browse by tag
bottom of page